CVS Stock Analysis: Buy, Sell, or Hold?
CVS - CVS HEALTH CORPORATION
$95.89
-1.26 (-1.30%)
▼
5d:
+5.9%
30d:
+24.87%
90d:
+22.18%
HOLD
MODERATE Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 06, 2026
0d
Smart Money Distribution
None View Scanner →
Strength: 6.9/10
Get Alerted When CVS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
3 traders called CVS this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: CVS is 7.1% above its trading range ($89.52). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: CVS is 7.1% above its trading range ($89.52). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$126.55
Based on 8.3% avg growth
INTRINSIC VALUE TODAY
$78.58
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 10.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CVS is currently trading at $95.89, which is considered extended relative to its 30-day fair value range of $75.51 to $89.52. From a valuation perspective, the stock is trading at a premium (Forward PE: 11.5) compared to its historical average (10.2). At these levels, the market is pricing in 4.1% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CVS is in a uptrend. The price is approaching resistance at $98.43. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CVS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CVS is in a uptrend. The price is approaching resistance at $98.43. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CVS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$75.51 -
$89.52
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
53.3%
Protect Your Profits
CVS is technically overbought (RSI 76). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+7.1% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($101.58)
- NEUTRAL: Market pricing in 4.1% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$75.51 -
$89.52
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$80.40
Resistance Level
$98.43
Current Trend
Uptrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
11.47
Wall Street Target
$101.58
(+5.9%)
Revenue Growth (YoY)
6.1%
Earnings Growth (YoY)
63.1%
Profit Margin
0.7%
Valuation Premium vs History
+4.1% premium
PE vs Historical
11.5 vs 10.2
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+4.1%
(market-implied from PE analysis)
1-Year Target
$99.82
(+4%)
2-Year Target
$103.91
(+8%)
3-Year Target
$108.17
(+13%)
3-Yr Target (if PE normalizes)
(PE: 11→10)
PE COMPRESSION
$96.23
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.1, Growth: 12.5%)
$262.82
(+174%)
Base:
(SPY PE: 11.5, Growth: 12.5%)
$136.55
(+42%)
Bear:
(PE: 9.7, Growth: 12.5%)
$116.07
(+21%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (43x PE), but valuation improves significantly next year (11x PE) as earnings recover.
Trailing PE: 43.03 | Current EPS (TTM): $2.28
Bull Case
$215.84
(+122%)
Analyst growth 100.0%, PE expands to 47.3
Base Case
$196.22
(+102%)
Market implied 100.0%, PE stable at 43.0
Bear Case
$66.71
(-31%)
Severe decline -20.0%, PE contracts to 36.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: May 15, 2026 5:18 PM ET
Data refreshes hourly during market hours. Next update: 6:18 PM
Data refreshes hourly during market hours. Next update: 6:18 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CVS showing a specific setup today?
Insider Activity (6 Months)
2
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
SELL
2026-02-24
Michael T. McCaul
BUY
2026-02-20
John Boozman
BUY
2026-01-29
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
UNH
UnitedHealth Group Incor… |
STRONG BUY
27 analysts |
$387 | 62 BUY |
|
CI
Cigna Corp |
STRONG BUY
25 analysts |
$341 | 65 BUY |
|
ELV
Elevance Health Inc |
STRONG BUY
22 analysts |
$389 | 57 HOLD |
|
HUM
Humana Inc |
HOLD
26 analysts |
$244 | 57 HOLD |
|
CNC
Centene Corp |
BUY
19 analysts |
$55 | 61 BUY |
Advanced CVS Option Strategies
Professional options setups generated by AI based on today's CVS price and gamma walls.
